Table 4. Association of LEPR K109R Genotypes With Clinical Pathological Parameters in NAFLD Patients With and Without Coronary Atherosclerosisa.
Clinical Characteristics | NAFLD+ Coronary Atherosclerosis+ | NAFLD+ Coronary Atherosclerosis- | ||||
---|---|---|---|---|---|---|
AA+GA, (n = 148) | GG, (n = 201) | P Value | AA+GA, (n = 50) | GG, (n = 155) | P Value | |
Gender | 0.650 | 0.962 | ||||
Male | 70 | 100 | 24 | 75 | ||
Female | 78 | 101 | 26 | 80 | ||
Age, y | 45.28 ± 11.59 | 47.00 ± 12.28 | 0.184 | 48.88 ± 10.32 | 46.04 ± 11.65 | 0.105 |
BMI, kg/m 2 | 24.67 ± 1.59 | 24.07 ± 1.69 | 0.001 | 24.34 ± 1.62 | 23.98 ± 1.65 | 0.176 |
ALT, U/L | 24.72 ± 11.73 | 22.80 ± 9.98 | 0.096 | 25.94 ± 13.30 | 22.52 ± 8.47 | 0.092 |
AST, U/L | 22.22 ± 6.93 | 20.79 ± 5.50 | 0.039 | 23.60 ± 9.01 | 20.86 ± 6.03 | 0.049 |
FPG, mmol/L | 5.31 ± 0.84 | 5.02 ± 0.67 | 0.001 | 5.39 ± 0.92 | 5.18 ± 0.71 | 0.094 |
TG, mmol/L | 2.06 ± 2.12 | 1.69 ± 1.18 | 0.039 | 2.00 ± 2.13 | 1.61 ± 1.13 | 0.101 |
TC, mmol/L | 4.96 ± 1.02 | 4.75 ± 0.96 | 0.051 | 4.92 ± 0.87 | 4.64 ± 1.01 | 0.084 |
HDL, mmol/L | 1.34 ± 0.71 | 1.40 ± 0.63 | 0.416 | 1.22 ± 0.31 | 1.35 ± 0.49 | 0.068 |
LDL, mmol/L | 3.55 ± 0.95 | 3.47 ± 0.98 | 0.456 | 3.32 ± 1.08 | 3.30 ± 0.88 | 0.873 |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; FPG, fasting blood glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease patients; P1, NAFLD group vs. control group; P2, coronary atherosclerosis group vs. control group; P3, NAFLD group vs. coronary atherosclerosis group; TG, triglyceride; TC, total cholesterol.
aValues are expressed as mean±SD.